Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic Cardiomyopathy.

Miller1, Berry, Missov

  • 1Cardiovascular Division, Department of Medicine, University of Minnesota, Mayo Mail Code 508, 420 Delaware Street SE, Minneapolis, MN 55455, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Sudden Death Seven Hours after Delivery-Air Found in the Heart.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Meningococcemia.

Archives of pediatrics·2010
Same author

Comment on berry and hachinski

Archives of neurology·2000
Same author

Optimal states and almost optimal adaptive measurements for quantum interferometry

Physical review letters·2000
Same author

A reconsideration of Wattieza Stockmans (here attributed to Cladoxylopsida) based on a new species from the Devonian of Venezuela.

Review of palaeobotany and palynology·2000
Same author

Discrete periodic melting point observations for nanostructure ensembles

Physical review letters·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Idiopathic cardiomyopathy, a common cause of heart failure, requires excluding other conditions. Current treatments focus on ACE inhibitors and maximizing dosages, with new therapies offering future hope.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Idiopathic cardiomyopathy is a prevalent cause of heart failure.
  • It is diagnosed by excluding other potential cardiac conditions.
  • Patient history is crucial for accurate diagnosis.

Purpose of the Study:

  • To review current understanding and management of idiopathic cardiomyopathy.
  • To highlight the role of ACE inhibitors in left ventricular dysfunction.
  • To discuss the importance of dose titration and emerging therapies.

Main Methods:

  • Literature review of idiopathic cardiomyopathy.
  • Analysis of current treatment guidelines for heart failure.
  • Overview of pharmacological interventions.

Related Experiment Videos

Main Results:

  • ACE inhibitors are first-line therapy for left ventricular dysfunction.
  • Maximizing drug dosages is essential for effective treatment.
  • Ongoing development of novel therapeutic agents.

Conclusions:

  • Accurate diagnosis of idiopathic cardiomyopathy relies on excluding other causes.
  • Optimized medical management is key to improving outcomes.
  • Future therapies hold promise for altering the disease's progression.